» Authors » Eva Martinez-Ojinaga

Eva Martinez-Ojinaga

Explore the profile of Eva Martinez-Ojinaga including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 271
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Salvador-Martin S, Pujol-Muncunill G, Bossacoma F, Navas-Lopez V, Gallego-Fernandez C, Segarra O, et al.
Br J Clin Pharmacol . 2020 Jun; 87(2):447-457. PMID: 32478906
Aims: Identifying DNA variants associated with trough serum anti-tumour necrosis factor (TNF) levels could predict response to treatment in inflammatory bowel disease (IBD). To date, no specific studies have been...
12.
Salvador-Martin S, Raposo-Gutierrez I, Navas-Lopez V, Gallego-Fernandez C, Moreno-Alvarez A, Solar-Boga A, et al.
Int J Mol Sci . 2020 May; 21(9). PMID: 32397546
Around a 20-30% of inflammatory bowel disease (IBD) patients are diagnosed before they are 18 years old. Anti-TNF drugs can induce and maintain remission in IBD, however, up to 30%...
13.
Martinez-Ojinaga E, Fernandez-Prieto M, Molina M, Polanco I, Urcelay E, Nunez C
BMC Gastroenterol . 2019 Jun; 19(1):91. PMID: 31196071
Background: Celiac disease (CD) is triggered by gluten and related prolamines in genetically susceptible individuals. We aimed to investigate the influence of HLA-DQ genotypes in clinical, serological and histological features...
14.
Lopez-Palacios N, Pascual V, Castano M, Bodas A, Fernandez-Prieto M, Espino-Paisan L, et al.
Dig Liver Dis . 2018 Jun; 50(11):1183-1188. PMID: 29903545
Background And Aim: To diagnose coeliac disease (CD) in individuals on a gluten free diet (GFD), we aimed to assess the utility of detecting activated γδ and CD8 T cells...
15.
Martinez-Ojinaga E, Molina M, Polanco I, Urcelay E, Nunez C
Rev Esp Enferm Dig . 2018 Apr; 110(7):421-426. PMID: 29699404
Aims: celiac disease is a multisystem immune-mediated disease triggered by gluten in genetically susceptible individuals. The HLA-DQ2 and/or HLA-DQ8 heterodimers are encoded by the main genetic predisposing factors and their...
16.
Crespo Escobar P, Castillejo G, Martinez-Ojinaga E, Donat E, Polanco I, Mearin M, et al.
Rev Esp Enferm Dig . 2018 Apr; 110(8):493-499. PMID: 29699403
Aim: to evaluate the influence of gluten consumption on celiac disease development and to describe its natural history in the Spanish cohort of the European PreventCD study. Methods: prospective multi-center...
17.
Polanco I, Weber T, Martinez-Ojinaga E, Molina M, Sarria J
Rev Esp Enferm Dig . 2017 Sep; 109(11):743-748. PMID: 28950706
Objective: The objective of the study was to assess the effectiveness of a point-of-care test (POCT) based on deamidated gliadin peptides (DGP) compared to the European Society for Paediatric Gastroenterology...
18.
Crespo-Escobar P, Mearin M, Hervas D, Auricchio R, Castillejo G, Gyimesi J, et al.
Am J Clin Nutr . 2017 Feb; 105(4):890-896. PMID: 28228423
We previously found that the introduction of small quantities of gluten at 4-6 mo of age did not reduce the risk of celiac disease (CD) in a group of high-risk...
19.
Vriezinga S, Auricchio R, Bravi E, Castillejo G, Chmielewska A, Crespo Escobar P, et al.
N Engl J Med . 2014 Oct; 371(14):1304-15. PMID: 25271603
Background: A window of opportunity has been suggested for reducing the risk of celiac disease by introducing gluten to infants at 4 to 6 months of age. Methods: We performed...
20.
Ramos E, Hernandez F, Andres A, Martinez-Ojinaga E, Molina M, Sarria J, et al.
Pediatr Transplant . 2013 Jun; 17(5):472-8. PMID: 23730927
PTLDs are a well-recognized and potentially fatal complication after intestinal transplantation. We analyzed the incidence, clinical features, and outcome in a 63 intestinal transplantation series performed in our unit between...